The breast and lung models suggested that the effect of EcSOD on invasive capacity may be related to heparanase expression, where cancer cells overexpressing EcSOD had diminished heparanase promoter activity, decreased heparanase transcription and activity, and increased intact heparan sulfate on cell surfaces [37,57]. Here, SOD3 is linked to cancer.